• 1

    Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ, 1991. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 147 :1338–1343.

    • Search Google Scholar
    • Export Citation
  • 2

    Stein MP, Edberg JC, Kimberly RP, Mangan EK, Bharadwaj D, Mold C, Du Clos TW, 2000. C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest 105 :369–376.

    • Search Google Scholar
    • Export Citation
  • 3

    Platonov AE, Shipulin GA, Vershinina IV, Dankert J, van de Winkel JG, Kuijper EJ, 1998. Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis 27 :746–750.

    • Search Google Scholar
    • Export Citation
  • 4

    Bredius RG, Derkx BH, Fijen CA, de Wit TP, de Haas M, Weening RS, van Winkel JG, Out TA, 1994. Fcγ receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170 :848–853.

    • Search Google Scholar
    • Export Citation
  • 5

    Yee AM, Phan HM, Zuniga R, Salmon JE, Musher DM, 2000. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis 30 :25–28.

    • Search Google Scholar
    • Export Citation
  • 6

    Pied S, Nussler A, Pontent M, Miltgen F, Matile H, Lambert PH, Mazier D, 1989. C-reactive protein protects against preerythrocytic stages of malaria. Infect Immun 57 :278–282.

    • Search Google Scholar
    • Export Citation
  • 7

    Druilhe P, Sabchareon A, Bouharoun-Tayoun H, Oeuvray C, Perignon JL, 1997. In vivo veritas: lessons from immunoglobulin-transfer experiments in malaria patients. Ann Trop Med Parasitol 91 :S37–S53.

    • Search Google Scholar
    • Export Citation
  • 8

    Bouharoun-Tayoun H, Druilhe P, 1992. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 60 :1473–1481.

    • Search Google Scholar
    • Export Citation
  • 9

    Braga EM, Barros RM, Reis TA, Fontes CJ, Morais CG, Martins MS, Krettli AU, 2002. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region. Am J Trop Med Hyg 66 :461–466.

    • Search Google Scholar
    • Export Citation
  • 10

    Taylor RR, Allen SJ, Greenwood BM, Riley EM, 1998. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg 58 :406–413.

    • Search Google Scholar
    • Export Citation
  • 11

    Oeuvray C, Theisen M, Rogier C, Trape JF, Jepsen S, Druilhe P, 2000. Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal. Infect Immun 68 :2617–2620.

    • Search Google Scholar
    • Export Citation
  • 12

    Aucan C, Traore Y, Tall F, Nacro B, Traore-Leroux T, Fumoux F, Rihet P, 2000. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infect Immun 68 :1252–1258.

    • Search Google Scholar
    • Export Citation
  • 13

    Shi YP, Nahlen BL, Kariuki S, Urdahl KB, McElroy PD, Roberts JM, Lal AA, 2001. Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. J Infect Dis 184 :107–111.

    • Search Google Scholar
    • Export Citation
  • 14

    Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, Looareesuwan S, Tokunaga K, 2002. Fcgamma receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. Parasitol Int 51 :361–366.

    • Search Google Scholar
    • Export Citation
  • 15

    Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM, 1991. Common west African HLA antigens are associated with protection from severe malaria. Nature 352 :595–600.

    • Search Google Scholar
    • Export Citation
  • 16

    Jiang XM, Arepally G, Poncz M, McKenzie SE, 1996. Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). J Immunol Methods 199 :55–59.

    • Search Google Scholar
    • Export Citation
  • 17

    Bredius RG, Derkx BH, Fijen CA, de Wit TP, de Haas M, Weening RS, van de Winkel JG, Out TA, 1994. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170 :848–853.

    • Search Google Scholar
    • Export Citation
  • 18

    Bredius RG, de Vries CE, Troelstra A, van Alphen L, Weening RS, van de Winkel JG, Out TA, 1993. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2. J Immunol 151 :1463–1472.

    • Search Google Scholar
    • Export Citation
  • 19

    Greenwood B, 1999. Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 93 :341–353.

  • 20

    Goetghebuer T, West TE, Wermenbol V, Cadbury AL, Milligan P, Lloyd-Evans N, Adegbola RA, Mulholland EK, Greenwood BM, Weber MW, 2000. Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia. Trop Med Int Health 5: 207–213.

    • Search Google Scholar
    • Export Citation
  • 21

    Rascu A, Repp R, Westerdaal NA, Kalden JR, van de Winkel JG, 1997. Clinical relevance of Fc gamma receptor polymorphisms. Ann N Y Acad Sci 815 :282–295.

    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 9 9 9
Full Text Views 250 148 3
PDF Downloads 48 33 2
 
 
 
 
 
 
 
 
 
 
 

ASSOCIATION OF Fcγ RECEPTOR IIa (CD32) POLYMORPHISM WITH SEVERE MALARIA IN WEST AFRICA

GRAHAM S. COOKEWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Medical Research Council Laboratories, Banjul, The Gambia; London School of Hygiene and Tropical Medicine, London, United Kingdom

Search for other papers by GRAHAM S. COOKE in
Current site
Google Scholar
PubMed
Close
,
CHRISTOPHE AUCANWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Medical Research Council Laboratories, Banjul, The Gambia; London School of Hygiene and Tropical Medicine, London, United Kingdom

Search for other papers by CHRISTOPHE AUCAN in
Current site
Google Scholar
PubMed
Close
,
ANDREW J. WALLEYWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Medical Research Council Laboratories, Banjul, The Gambia; London School of Hygiene and Tropical Medicine, London, United Kingdom

Search for other papers by ANDREW J. WALLEY in
Current site
Google Scholar
PubMed
Close
,
SHELLEY SEGALWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Medical Research Council Laboratories, Banjul, The Gambia; London School of Hygiene and Tropical Medicine, London, United Kingdom

Search for other papers by SHELLEY SEGAL in
Current site
Google Scholar
PubMed
Close
,
BRIAN M. GREENWOODWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Medical Research Council Laboratories, Banjul, The Gambia; London School of Hygiene and Tropical Medicine, London, United Kingdom

Search for other papers by BRIAN M. GREENWOOD in
Current site
Google Scholar
PubMed
Close
,
DOMINIC P. KWIATKOWSKIWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Medical Research Council Laboratories, Banjul, The Gambia; London School of Hygiene and Tropical Medicine, London, United Kingdom

Search for other papers by DOMINIC P. KWIATKOWSKI in
Current site
Google Scholar
PubMed
Close
, and
ADRIAN V. S. HILLWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Medical Research Council Laboratories, Banjul, The Gambia; London School of Hygiene and Tropical Medicine, London, United Kingdom

Search for other papers by ADRIAN V. S. HILL in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

Malaria continues to claim the lives of more children worldwide than any other infectious disease, and improved understanding of disease immunology is a priority for the development of new therapeutic and vaccination strategies. FcγRIIa (CD32) contains a polymorphic variant (H/R131) that has been associated with variability in susceptibility to both bacterial diseases and Plasmodium falciparum parasitemia. We investigated the role of this polymorphism in West Africans with mild and severe malarial disease. The HH131 genotype was significantly associated with susceptibility to severe malaria (P = 0.03, odds ratio = 1.40, 95% confidence interval = 1.02–1.91). In contrast to studies of parasitemia, the presence of the R131 allele, rather than the RR131 genotype, appeared to be the important factor in protection from disease. This is the first evidence for an association between CD32 polymorphism and severe malaria and provides an example of balancing selective pressures from different infectious diseases operating at the same genetic locus.

Author Notes

Reprint requests: Graham S. Cooke, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom, E-mail: grahamc@well.ox.ac.uk.
Save